pemafibrate
Sign in to savePemafibrate, sold under the brand name Parmodia, is a peroxisome proliferator-activated receptor alpha (PPARα) agonist. It is developed and marketed by Kowa Pharmaceuticals.
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 490.21
Show 4 more facts
- chemical formula
- C₂₈H₃₀N₂O₆
- canonical SMILES
- CCC(C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3
- isomeric SMILES
- CC[C@H](C(=O)O)OC1=CC=CC(=C1)CN(CCCOC2=CC=C(C=C2)OC)C3=NC4=CC=CC=C4O3
- Commons category
- Pemafibrate
Sources (2)
via Wikidata · CC0
~2 min read
Encyclopedic overview
1 sectionsContents
- References
{{Infobox drug | drug_name = | INN = | type = | IUPAC_name = (2R)-2-[3-({1,3-Benzoxazol-2-yl[3-(4-methoxyphenoxy)propyl]amino}methyl)phenoxy]butanoic acid | image = Pemafibrate.svg | image_class = skin-invert-image | width = | alt = | caption =
| pronounce = | tradename = Parmodia | Drugs.com = | MedlinePlus = | DailyMedID = | pregnancy_AU = | pregnancy_AU_comment = | pregnancy_category= | routes_of_administration = Oral | class = | ATCvet = | ATC_prefix = C10 | ATC_suffix = AB12 | ATC_supplemental =
Excerpted from Wikipedia’s “pemafibrate” article, available under the CC BY-SA 4.0 licence.